Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-01-09Clinical Trial Update: X-396 Capsule in Advanced NSCLC Patients With ROS1 Gene Rearrangement [Phase 2]
Phase 2 clinical trial update for X-396 capsule in advanced non-small cell lung cancer with ROS1 gene rearrangement.
-
CLINICAL_TRIALS trial_result · 2020-01-07Clinical Trial Update: Anlotinib Plus Docetaxel for the Treatment of EGFR Wild-type Advanced Non-small-cell Lung Cancer [Phase 2]
Phase 2 clinical trial evaluating anlotinib in combination with docetaxel for EGFR wild-type advanced non-small-cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2020-01-06Clinical Trial Update: Study to Evaluate Safety, Pharmacokinetics, and Efficacy of Rociletinib (CO-1686) in Previously Treated Mutant Epidermal Growth Factor Receptor (EGFR) in Non-Small Cell Lung Cancer (NSCLC) Patients [Phase 1, Phase 2]
Clinical trial update on rociletinib (CO-1686) in previously treated EGFR-mutant NSCLC; study phases 1/2 terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2020-01-06Clinical Trial Update: MTD Study PXD-101 in Combination With Paclitaxel + Carboplatin in Chemotherapy-Naive Patients With Stage IV NSCLC [Phase 1, Phase 2]
Clinical trial update for MTD study of PXD-101 in combination with paclitaxel and carboplatin in chemotherapy-naive patients with Stage IV n…
-
CLINICAL_TRIALS trial_result · 2020-01-06Clinical Trial Update: Metformin in Non Small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 trial of metformin in non small cell lung cancer was terminated; results posted in 2020.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-12-30Clinical Trial Update: Sintilimab Combined With Bevacizumab for Brain Metastases From Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating sintilimab in combination with bevacizumab for brain metastases in non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2019-12-30Clinical Trial Update: Dacomitinib + Pemetrexed for Patients With Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC) [Phase 1]
Phase 1 trial investigating dacomitinib combined with pemetrexed in advanced non-squamous non-small cell lung cancer has been terminated wit…
-
CLINICAL_TRIALS trial_result · 2019-12-30Clinical Trial Update: OSI-774 (Erlotinib, Tarceva) in Elderly Patients [Phase 2]
Phase 2 trial evaluating erlotinib (OSI-774, Tarceva) in elderly patients with non-small cell lung cancer has been completed.
-
CLINICAL_TRIALS trial_result · 2019-12-26Clinical Trial Update: Efficacy, Safety and Pharmacokinetics Study of Antroquinonol to Treat NSCLC [Phase 2]
A Phase 2 trial evaluating antroquinonol for non-small cell lung cancer (Stage IV) has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2019-12-26Clinical Trial Update: Erlotinib Hydrochloride With or Without Bevacizumab in Treating Patients With Stage IV Non-small Cell Lung Cancer With Epidermal Growth Factor Receptor Mutations [Phase 2]
Phase 2 trial evaluating erlotinib with or without bevacizumab in stage IV non-small cell lung cancer with EGFR mutations has completed, wit…
-
CLINICAL_TRIALS trial_result · 2019-12-26Clinical Trial Update: Anlotinib Combined With Nivolumab for Non-Small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial investigating the combination of anlotinib with nivolumab for non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2019-12-24Clinical Trial Update: Ponatinib in Advanced NSCLC w/ RET Translocations [Phase 2]
Phase 2 trial of ponatinib in advanced non-small cell lung cancer with RET translocations has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-12-20Clinical Trial Update: A Study of Erlotinib in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer [Phase 3]
Phase 3 trial update of erlotinib in locally advanced or metastatic non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2019-12-19Clinical Trial Update: A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer, Non-small Cell Lung Cancer, or Melanoma That Has Spread to the Brain [Phase 2]
Phase 2 trial update of abemaciclib in participants with brain-metastatic breast cancer, non-small cell lung cancer, or melanoma; study comp…
-
CLINICAL_TRIALS trial_result · 2019-12-16Clinical Trial Update: Evaluating Combination Therapy Using Autologous Dendritic Cells Pulsed With Antigen Peptides and Nivolumab for Subjects With Advanced Non-Small Cell Lung Cancer [Phase 1, Phase 2]
A clinical trial evaluating a combination therapy of autologous dendritic cells pulsed with antigen peptides plus nivolumab in advanced non-…
-
CLINICAL_TRIALS trial_result · 2019-12-13Clinical Trial Update: Bortezomib With or Without Docetaxel in Treating Patients With Relapsed or Refractory Advanced Non-Small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial evaluating bortezomib with or without docetaxel in relapsed or refractory advanced non-small cell lung cancer has com…
-
CLINICAL_TRIALS trial_result · 2019-12-13Clinical Trial Update: Study of Pembrolizumab (MK-3475) in Participants With Progressive Locally Advanced or Metastatic Carcinoma, Melanoma, or Non-small Cell Lung Carcinoma (P07990/MK-3475-001/KEYNOTE-001) [Phase 1]
Phase 1 study of pembrolizumab (MK-3475) in participants with progressive locally advanced/metastatic carcinoma, melanoma, or non-small cell…
-
CLINICAL_TRIALS trial_result · 2019-12-10Clinical Trial Update: The Role of Brain Radiotherapy in Patients With Asymptomatic Brain Metastasis in the Era of Targeted Therapy for NSCLC [Phase 2]
A Phase 2 clinical trial evaluating the role of brain radiotherapy in asymptomatic brain metastases in non-small cell lung cancer patients u…
-
CLINICAL_TRIALS trial_result · 2019-12-10Clinical Trial Update: An Exploration of Apatinib Combined With S-1 in Patients With Advanced Non-small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial exploring the combination of apatinib and S-1 in advanced non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2019-12-09Clinical Trial Update: Chemotherapy With Pembrolizumab Continuation After Progression to PD-1/L1 Inhibitors [Phase 2]
A Phase 2 trial investigating continuation of chemotherapy with pembrolizumab after progression on PD-1/PD-L1 inhibitors in metastatic non-s…
-
CLINICAL_TRIALS trial_result · 2019-12-03Clinical Trial Update: Trametinib in Patients With Advanced Neurofibromatosis Type 1 (NF1)-Mutant Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial update of trametinib in patients with NF1-mutant non-small cell lung cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2019-12-02Clinical Trial Update: Study of Anlotinib Plus Chemoradiotherapy in Patients With Locally Advanced NSCLC [Phase 1, Phase 2]
Phase 1/2 trial evaluating anlotinib in combination with chemoradiotherapy for locally advanced non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2019-11-29Clinical Trial Update: Phase III Open Label First Line Therapy Study of MEDI 4736 (Durvalumab) With or Without Tremelimumab Versus SOC in Non Small-Cell Lung Cancer (NSCLC) [Phase 3]
Phase III open-label study evaluating durvalumab with or without tremelimumab versus standard-of-care in first-line non-small cell lung canc…
-
CLINICAL_TRIALS trial_result · 2019-11-29Clinical Trial Update: A Study of Neoadjuvant Chemotherapy Plus Anlotinib in Stage III(N2) Non-small-cell Lung Cancer [Phase 2]
Phase 2 trial update evaluating neoadjuvant chemotherapy plus anlotinib for Stage III non-small-cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2019-11-29Clinical Trial Update: Single Agent Chemotherapy +/- Nivolumab in Patients With Advanced Squamous or Non-squamous NSCLC With Primary Resistance to Prior PD-1 or PDL-1 Inhibitor [Phase 2]
Phase 2 trial evaluating single agent chemotherapy with or without nivolumab in advanced NSCLC patients with primary resistance to prior PD-…